Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Seth Klarman’s Picks Beat the Market in Q1

Seth Klarman‘s Baupost Group is one of the largest hedge funds in the world, with about $27 billion in assets under management. The fund posted a small loss in 2015, but our calculations show that its stock picks performed well in the first quarter of this year. The weighted average returns of the firm’s 18 holdings in companies with a market capitalization of at least $1.00 billion came in at 2.9% during the quarter, based on the size of those positions at the beginning of the period. This compares very favorably to the less than 1% gain posted by the S&P 500 index during the same period. Let’s take a look at some of the stocks that were responsible for the most volatility in Baupost’s portfolio during the quarter.

Our research determined that following the small-cap stocks that hedge funds are collectively bullish on can help a smaller investor beat the S&P 500 by around 95 basis points per month (see more details here).

#5 Theravance Biopharma Inc (NASDAQ:TBPH)

 – Shares Owned by Baupost Group (as of December 31): 6.42 Million

 – Value of Holding (as of December 31): $105.22 Million

Baupost’s Theravance holding was left unchanged during the fourth quarter at 6.42 million shares. The stock price of the $802 million biopharmaceutical company shot up by more than 20% during the first three months of 2016, making it one of the top performers in the fund’s portfolio. In its recently released financial results for the quarter ending December 31, Theravance Biopharma Inc (NASDAQ:TBPH) posted a net loss of $1.23 per share, which was $0.39 ahead of estimates, while quarterly revenue of $3.89 million marked a 172% increase on a year-over-year basis. The company also recently sold 1.3 million shares to Glaxo Group Limited, which held a 22% stake in the company at the end of last year. Neil Woodford‘s Woodford Investment Management significantly boosted its stake in Theravance Biopharma Inc (NASDAQ:TBPH) during the October-to-December period, to 5.06 million shares.

Follow Theravance Biopharma Inc. (NASDAQ:TBPH)
Trade (NASDAQ:TBPH) Now!

#4 Twenty-First Century Fox Inc (NASDAQ:FOXA)

 – Shares Owned by Baupost Group (as of December 31): 4.10 Million

 – Value of Holding (as of December 31): $111.29 Million

Another one of Baupost’s unchanged holdings, Twenty-First Century Fox posted modest gains of 5.27% during the first quarter. While concerns about the media market in the U.S continue to linger, Twenty-First Century Fox Inc (NASDAQ:FOXA) is gaining serious ground in India through its Indian subsidiary Star India, which has doubled its market share to 23% in the last five years. The subsidiary is expected to hit $500 million in EBITDA by 2018 and $1.00 billion by 2020. Recently, Twenty-First Century Fox expanded the role of Star India’s chief executive Uday Shankar to include that of Chairman. Jeffrey Ubben‘s ValueAct Capital owns about 47.33 million shares of Twenty-First Century Fox Inc (NASDAQ:FOXA) as of December 31.

Follow Twenty-First Century Fox Inc. (NASDAQ:TFCF,TFCFA)

Three more of Mr. Klarman’s top stock picks are studied on the next page.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.